Zydus Lifesciences Ltd. - Research Center
532321 ZYDUSLIFE Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
5,115.00 |
4,379.70 |
3,849.60 |
4,132.30 |
3,852.80 |
Operating profit |
1,790.40 |
1,223.30 |
816.20 |
1,101.90 |
1,216.80 |
Interest |
180.60 |
104.70 |
66.60 |
68.30 |
34.80 |
Gross profit |
2,226.70 |
1,279.50 |
829.20 |
1,132.70 |
1,262.80 |
EPS (Rs) |
15.67 |
7.73 |
4.33 |
4.04 |
8.51 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
616.90 |
160.90 |
79.60 |
99.10 |
80.80 |
Stock adjustment |
-70.00 |
81.10 |
-19.30 |
-27.60 |
-82.90 |
Raw material |
1,582.60 |
1,270.70 |
1,273.30 |
1,355.70 |
1,124.20 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
729.40 |
642.70 |
582.20 |
622.70 |
570.80 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1,082.60 |
1,161.90 |
1,197.20 |
1,079.60 |
1,023.90 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
246.10 |
247.10 |
242.80 |
235.90 |
223.00 |
Taxation |
394.70 |
249.80 |
142.50 |
163.50 |
168.60 |
Net profit / loss |
1,585.90 |
782.60 |
443.90 |
414.00 |
871.20 |
Extra ordinary item |
- |
- |
- |
-319.30 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
101.20 |
101.20 |
102.40 |
102.40 |
102.40 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
35.00 |
27.93 |
21.20 |
26.67 |
31.58 |
GPM (%) |
38.85 |
28.18 |
21.10 |
26.77 |
32.10 |
NPM (%) |
27.67 |
17.24 |
11.30 |
9.78 |
22.15 |